Key HighlightsOperational Status: Effective as of January 12, 2026, following ratification by Russian President Vladimir Putin in late 2025.Troop Deployment: The pact permits up...
LumiraDx Healthcare Private Limited, a next-generation point of care diagnostics testing company announced it has launched its highly sensitive C-Reactive Protein (CRP) point of...